- Target
- IRF-3
- Reactivity
- Human
- Application
- WB,IF,ELISA
- MW(Calculated)
- 47kD
- MW(Observed)
- 60kD
- Host Species
- Rabbit
- Isotype
- IgG, Kappa
- Conjugate/Modification
- Phospho
- Modification site
- --
- Recommended Dilution Ratio
- WB 1:1000-1:15000;IF 1:200-1:1000;ELISA 1:5000-1:20000;
- Form
- PBS, 50% glycerol, 0.05% Proclin 300, 0.05%BSA
- Source
- --
- Purification
- Protein A
- Purity
- --
- storageCondition
- -15°C to -25°C/1 year(Do not lower than -25°C)
- Concentration
- --
- Clonality
- --
- Clone No.
- PT0984R
- Immunogen
- --
- Sequence
- --
- Specificity
- IRF3 (Phospho Ser386) Monoclonal Antibody detects endogenous levels of IRF-3 protein only when phosphorylated at S386.The name of modified sites may be influenced by many factors, such as species (the modified site was not originally found in human samples) and the change of protein sequence (the previous protein sequence is incomplete, and the protein sequence may be prolonged with the development of protein sequencing technology). When naming, we will use the "numbers" in historical reference to keep the sites consistent with the reports. The antibody binds to the following modification sequence (lowercase letters are modification sites):ASsLE
- Gene Name
- IRF3
- Protein Name
- Interferon regulatory factor 3
- Other Name
- IRF3;Interferon regulatory factor 3;IRF-3
- Organism-1
- Human
- Gene ID-1
- 3661
- SwissProt-1
- Q14653
- Organism-2
- Mouse
- Gene ID-2
- --
- SwissProt-2
- P70671
- Organism-3
- --
- Gene ID-3
- --
- SwissProt-3
- --
- Organism-4
- --
- gene ID-4
- --
- SwissProt-4
- --
- Cellular Localization
- Cytoplasm . Nucleus . Mitochondrion . Shuttles between cytoplasmic and nuclear compartments, with export being the prevailing effect (PubMed:10805757). When activated, IRF3 interaction with CREBBP prevents its export to the cytoplasm (PubMed:10805757). Recruited to mitochondria via TOMM70:HSP90AA1 upon Sendai virus infection (PubMed:25609812). .